{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:19:17Z","timestamp":1790727557570,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology","doi-asserted-by":"publisher","award":["DST\/INSPIRE\/03\/2021\/001186"],"award-info":[{"award-number":["DST\/INSPIRE\/03\/2021\/001186"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology","doi-asserted-by":"publisher","award":["SR\/FST\/COLLEGE-\/2019\/814"],"award-info":[{"award-number":["SR\/FST\/COLLEGE-\/2019\/814"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002915","name":"Fondation pour la Recherche M\u00e9dicale","doi-asserted-by":"publisher","award":["FRM EQU202103012588"],"award-info":[{"award-number":["FRM EQU202103012588"]}],"id":[{"id":"10.13039\/501100002915","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014809","name":"Institut Chevreul","doi-asserted-by":"publisher","award":["FR CNRS 2638"],"award-info":[{"award-number":["FR CNRS 2638"]}],"id":[{"id":"10.13039\/501100014809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022029","name":"Cambridge Crystallographic Data Centre","doi-asserted-by":"publisher","award":["CCDC 2517409"],"award-info":[{"award-number":["CCDC 2517409"]}],"id":[{"id":"10.13039\/501100022029","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.bioorg.2026.109644","type":"journal-article","created":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T16:40:41Z","timestamp":1771000841000},"page":"109644","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Isoniazid-derived vanillin and Salicylaldehyde Hydrazones: Promising Antimycobacterials with KatG-dependent activation"],"prefix":"10.1016","volume":"173","author":[{"given":"Nikita","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francoise","family":"Roquet-Baneres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natacha","family":"Henry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Anand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Roussel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Kremer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vipan","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2026.109644_bb0005","article-title":"Strengthening the global response to tuberculosis: insights from the 2024 WHO global TB report","volume":"39","author":"Estaji","year":"2025","journal-title":"J. Clin. Tuberc. Other Mycobact. Dis."},{"issue":"4","key":"10.1016\/j.bioorg.2026.109644_bb0010","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1080\/17460441.2024.2319042","article-title":"In silico drug design strategies for discovering novel tuberculosis therapeutics","volume":"19","author":"Canales","year":"2024","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.bioorg.2026.109644_bb0015","series-title":"Global tuberculosis report 2024","author":"World Health Organization","year":"2024"},{"issue":"38","key":"10.1016\/j.bioorg.2026.109644_bb0020","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202402933","article-title":"Isoniazid hybrids as potential antitubercular agents","volume":"9","author":"Mishra","year":"2024","journal-title":"ChemistrySelect"},{"issue":"1","key":"10.1016\/j.bioorg.2026.109644_bb0025","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3390\/pharmaceutics15010079","article-title":"In vivo toxicity, redox-modulating capacity and intestinal permeability of novel aroylhydrazone derivatives as anti-tuberculosis agents","volume":"15","author":"Valcheva","year":"2022","journal-title":"Pharmaceutics"},{"issue":"6","key":"10.1016\/j.bioorg.2026.109644_bb0030","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1111\/j.1365-2958.2007.05761.x","article-title":"The mycobacterium tuberculosis FAS-II condensing enzymes: their role in mycolic acid biosynthesis, acid-fastness, pathogenesis and in future drug development","volume":"64","author":"Bhatt","year":"2007","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.bioorg.2026.109644_bb0035","article-title":"Unlocking InhA: novel approaches to inhibit Mycobacterium tuberculosis","volume":"147","author":"Wahan","year":"2024","journal-title":"Bioorg. Chem."},{"issue":"24","key":"10.1016\/j.bioorg.2026.109644_bb0040","doi-asserted-by":"crossref","first-page":"13881","DOI":"10.1073\/pnas.2235848100","article-title":"The isoniazid-NAD adduct is a slow, tight-binding inhibitor of InhA, the Mycobacterium tuberculosis enoyl reductase: adduct affinity and drug resistance","volume":"100","author":"Rawat","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"5144","key":"10.1016\/j.bioorg.2026.109644_bb0045","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1126\/science.8284673","article-title":"inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis","volume":"263","author":"Banerjee","year":"1994","journal-title":"Science"},{"issue":"26","key":"10.1016\/j.bioorg.2026.109644_bb0050","doi-asserted-by":"crossref","first-page":"8235","DOI":"10.1021\/bi00026a004","article-title":"Enzymic characterization of the target for isoniazid in Mycobacterium tuberculosis","volume":"34","author":"Qu\u00e9mard","year":"1995","journal-title":"Biochemistry"},{"issue":"1","key":"10.1016\/j.bioorg.2026.109644_bb0055","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1054\/tuld.1998.0002","article-title":"Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update","volume":"79","author":"Ramaswamy","year":"1998","journal-title":"Tuber. Lung Dis."},{"issue":"4","key":"10.1016\/j.bioorg.2026.109644_bb0060","doi-asserted-by":"crossref","DOI":"10.1111\/cts.13795","article-title":"Efficacy, safety, and pharmacokinetics of isoniazid affected by NAT2 polymorphisms in patients with tuberculosis: a systematic review","volume":"17","author":"Surarak","year":"2024","journal-title":"Clin. Transl. Sci."},{"issue":"4","key":"10.1016\/j.bioorg.2026.109644_bb0065","doi-asserted-by":"crossref","first-page":"361","DOI":"10.3390\/ph14040361","article-title":"New InhA inhibitors based on expanded triclosan and di-triclosan analogues to develop a new treatment for tuberculosis","volume":"14","author":"Chetty","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bioorg.2026.109644_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.135325","article-title":"Synthesis of isoniazid analogs with promising antituberculosis activity and bioavailability: biological evaluation and computational studies","volume":"1283","author":"Gavadia","year":"2023","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2026.109644_bb0075","article-title":"Advancements in isoniazid-based heterocyclic derivatives as potent anti-tubercular agents: a comprehensive review of synthesis, SAR and biological activity (2017\u20132023)","author":"Garg","year":"2025","journal-title":"Synlett"},{"issue":"10","key":"10.1016\/j.bioorg.2026.109644_bb0080","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.3390\/ph15101301","article-title":"Isoniazid linked to sulfonate esters via hydrazone functionality: design, synthesis, and evaluation of antitubercular activity","volume":"15","author":"Ko\u00e7ak Aslan","year":"2022","journal-title":"Pharmaceuticals"},{"issue":"11","key":"10.1016\/j.bioorg.2026.109644_bb0085","doi-asserted-by":"crossref","first-page":"981","DOI":"10.2217\/fmb-2019-0040","article-title":"Hydrazone, benzohydrazones and isoniazid-acylhydrazones as potential antituberculosis agents","volume":"14","author":"Sampiron","year":"2019","journal-title":"Future Microbiol."},{"issue":"8","key":"10.1016\/j.bioorg.2026.109644_bb0090","doi-asserted-by":"crossref","first-page":"e01003","DOI":"10.1128\/AAC.00011-21","article-title":"Biological and biochemical evaluation of isatin-isoniazid hybrids as bactericidal candidates against Mycobacterium tuberculosis","volume":"65","author":"Johansen","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bioorg.2026.109644_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114531","article-title":"Designing quinoline-isoniazid hybrids as potent anti-tubercular agents inhibiting mycolic acid biosynthesis","volume":"239","author":"Alcaraz","year":"2022","journal-title":"Eur. J. Med. Chem."},{"issue":"10","key":"10.1016\/j.bioorg.2026.109644_bb0100","doi-asserted-by":"crossref","first-page":"3544","DOI":"10.1002\/jhet.4072","article-title":"Synthesis of isoniazid-1,2,3-triazole conjugates: antitubercular, antimicrobial evaluation and molecular docking study","volume":"57","author":"Badar","year":"2020","journal-title":"J. Heterocyclic Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2026.109644_bb0105","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/cbdd.13984","article-title":"1H-1,2,3-triazole embedded isatin-benzaldehyde-bis(heteronuclearhydrazones): design, synthesis, antimycobacterial, and cytotoxic evaluation","volume":"99","author":"Sharma","year":"2022","journal-title":"Chem. Biol. Drug Des."},{"issue":"7","key":"10.1016\/j.bioorg.2026.109644_bb0110","doi-asserted-by":"crossref","first-page":"177","DOI":"10.22270\/jddt.v13i7.6159","article-title":"Therapeutic aspects of biologically potent vanillin derivatives: A critical review","volume":"13","author":"Raju","year":"2023","journal-title":"J. Drug Deliv. Ther."},{"key":"10.1016\/j.bioorg.2026.109644_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.tube.2024.102545","article-title":"Preclinical tests for salicylhydrazones derivatives to explore their potential for new antituberculosis agents","volume":"148","author":"Ieque","year":"2024","journal-title":"Tuberculosis"},{"issue":"18","key":"10.1016\/j.bioorg.2026.109644_bb0120","doi-asserted-by":"crossref","first-page":"5824","DOI":"10.3390\/molecules27185824","article-title":"Identification of small molecule inhibitors against mycobacteria in activated macrophages","volume":"27","author":"Vande Voorde","year":"2022","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.bioorg.2026.109644_bb0125","doi-asserted-by":"crossref","DOI":"10.1093\/femspd\/ftac032","article-title":"Mycobacterial response to an acidic environment: protective mechanisms","volume":"80","author":"Rai","year":"2022","journal-title":"Pathog. Dis."},{"issue":"3","key":"10.1016\/j.bioorg.2026.109644_bb0130","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/CMR.00159-19","article-title":"Caseum: a niche for Mycobacterium tuberculosis drug-tolerant persisters","volume":"33","author":"Sarathy","year":"2020","journal-title":"Clin. Microbiol. Rev."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004520682600180X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004520682600180X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T12:00:24Z","timestamp":1777464024000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004520682600180X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":26,"alternative-id":["S004520682600180X"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109644","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Isoniazid-derived vanillin and Salicylaldehyde Hydrazones: Promising Antimycobacterials with KatG-dependent activation","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109644","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109644"}}